S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7124 +0.21%
PRE-MKT · 08:30 ET
Market ClerkRecap
Thu Oct 22 · pre-market6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
GK
INSIDER · PVLA · PALVELLA THERAPEUTICS, INC. · CHIEF OPERATING OFFICER

Goin Kathleen

Every open-market transaction filed under this name, Aug 19 to Sep 16.

Filings
8
0 buys · 8 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 16PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell1,654$153.24$253K−19.1%
Sep 16PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell989$152.36$151K−18.7%
Sep 16PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell1,659$151.16$251K−18.0%
Aug 19PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell302$156.77$47K−21.0%
Aug 19PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell102$155.59$16K−20.4%
Aug 19PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell400$153.00$61K−19.0%
Aug 19PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell1,998$151.80$303K−18.4%
Aug 19PVLAPALVELLA THERAPEUTICS, INC.Chief Operating OfficerSell1,500$151.39$227K−18.1%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.